FI Works founder Keith Henkel says community banks and credit unions have the data, but lack a way to turn a warning sign into a call to the right person.
FI Works, which builds a relationship intelligence and engagement platform for community banks and credit unions, has launched Signals, a feature that uses machine learning to spot households likely to add a product, take up digital services or leave the
Netcall's Pol Brouckaert argues that as AI makes fake documents easier to produce, checks on whether evidence can be trusted must sit inside workflows.
Businesses have spent years automating the processing of claims, applications and supporting documents.
N26 is partnering with Franklin Templeton to launch a digital retirement account in Germany, offering ETF investments and government-backed incentives from January 2027.
N26 today announced the upcoming launch of its new private retirement account (Altersvorsorgedepot) in Germany.
A 15-year-old's airborne pathogen monitor built from a fan and filter paper highlights how grassroots biotech innovation is reaching underserved communities.
A 15-year-old's airborne pathogen monitor built from a fan and filter paper highlights how grassroots biotech innovation is reaching underserved communities.
A wildfire-suppression specialist is redeploying its cold-weather aircraft fleet to map critical minerals, bridging aerospace and resource exploration.
A wildfire-suppression specialist is redeploying its cold-weather aircraft fleet to map critical minerals, bridging aerospace and resource exploration.
A simulation-based hiring platform targets aerospace and defence's worsening talent crunch as AI erodes the reliability of traditional screening signals.
A simulation-based hiring platform targets aerospace and defence's worsening talent crunch as AI erodes the reliability of traditional screening signals.
Nasdaq-listed Solmate says it plans to resell UAE-sourced GPU capacity for AI training and inference, with payment options including Solana stablecoins.
The EMA's advisory committee recommended secukinumab for patients aged 12 and over with moderate to severe hidradenitis suppurativa, with an EC decision expected within